Supporting this, NH patients also displayed an increased frequency of GM-CSF–producing CD4+ and CD8+ T cells, which have been implicated in the activation of innate immune cells and correlate with MS disease activity, as high blood and CSF levels associate with worse outcomes (40, 41). Here, CD8A is linked to myeloid sarcoma.